Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
M&A activity
confidence 92%
filed 2026-06-09
Item 1.01
NexPoint's operating partnership entered into a Loan Purchase and Sale Agreement on June 5, 2026, to acquire a $27.2 million term loan (the Waterford Loan) from NexBank Capital. This represents a material capital deployment and acquisition of a financial asset that management has identified as the "first deployment of capital in the Delaware statutory trust bridge-lending program." The transaction is funded via the company's revolving credit facility and involves assumption of the lender role under the underlying credit agreement, constituting a material definitive agreement under Item 1.01.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-09
Item 5.07
AXT Inc. held its Annual Meeting of Stockholders on June 4, 2026, with shareholders voting on five proposals: election of two Class I directors (Dr. Morris Young and Dr. David Chang), advisory vote on executive compensation, ratification of BPM as independent auditor, approval of an amendment to increase authorized common shares from 70 million to 120 million, and approval of an adjournment proposal. The filing discloses the voting results and outcomes for each matter.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-09
Item 5.07
This is a clear disclosure of shareholder vote results from the 2026 Annual Meeting of Stockholders held on June 9, 2026. The filing reports voting outcomes for two proposals: (1) election of directors Jenn Adams and Charles J. Casamento, and (2) ratification of Grant Thornton LLP as independent auditor. The detailed vote tallies (For, Against, Withheld, Abstain, Broker Non-Votes) are presented in tabular form, which is the standard format for Item 5.07 disclosures of shareholder meeting results.
View raw filing on EDGAR →
8-K
Earnings release
confidence 92%
filed 2026-06-09
Item 2.02
Uranium Energy Corp issued a news release on June 9, 2026 disclosing financial highlights and operational updates for the third quarter of fiscal year 2026 ended April 30, 2026, including the filing of its Form 10-Q with interim condensed consolidated financial statements and management's discussion and analysis.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-09
Item 5.07
This is a classic Item 5.07 disclosure of shareholder vote results from the annual meeting held June 9, 2026. The filing reports voting outcomes on four proposals: election of director Robert E. Cauley (4,126,106 for), ratification of BDO USA as auditor (7,408,328 for), approval of Rights Agreement amendment (4,139,041 for), and advisory vote on executive compensation (4,120,960 for). All proposals passed with substantial majorities, making this a material disclosure of shareholder actions.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-09
Item 5.02
The disclosure centers on the appointment of Ryan Panopio as Chief Investment Officer effective June 3, 2026, a newly created executive role. While the filing also includes compensatory details (base salary of $380,000, equity awards, and incentive targets), the principal action disclosed is the appointment itself. The appointment is material given the strategic importance emphasized by the CEO and the executive's substantial experience in real estate investment and capital markets, which directly supports the Company's stated growth objectives.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-09
Item 1.01
VolitionRx entered into a securities purchase agreement on June 7, 2026, to sell 2,960,000 shares of common stock and 1,480,000 common stock purchase warrants at $1.55 per unit, raising approximately $4.1 million in net proceeds with additional dilutive potential from warrant exercises.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-06-09
Brand Engagement Network Inc. entered into definitive agreements on June 8, 2026, establishing INTERVENT Health AI, Inc., a 50/50 joint venture with INTERVENT International, LLC. The filing discloses material terms including exclusive five-year North American commercialization arrangements, revenue-sharing provisions (35% to BEN from North American activities, 50% from international reseller arrangements), governance structure, and significant equity issuances (32.5 million Class A shares to each party plus 5 million Class B Preferred shares). This constitutes a material acquisition/formation activity under Item 1.01 that would affect a reasonable investor's assessment of the company's strategic direction and financial interests.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-09
The filing discloses multiple executive appointments on June 2, 2026: Loïc Gautier as Chief Financial Officer (US$150,000 annual base salary), Binglin Yu as Chief Technology Officer (RMB 55,000/month), and Hongwei Zhang as Chief Revenue Officer (RMB 55,000/month). While the filing also includes the departure of Chief Operating Officer Ade Irawan, the principal focus and substance of the disclosure centers on the three new C-suite appointments with detailed biographical information and compensation terms, making exec_appointment the most salient event type.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-09
The filing discloses the appointment of James Sapirstein as Chief Executive Officer of Cocrystal Pharma, effective June 3, 2026. While the disclosure also includes compensatory arrangements (base salary of $265,000, performance bonus, and stock option grants), the principal disclosed action is the appointment of a new CEO to replace co-CEOs Sam Lee and James Martin. This is a material executive change affecting the company's leadership structure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-09
Item 1.01
22nd Century Group issued new warrant inducement agreements (Inducement Warrants) to purchase common stock at a significantly reduced exercise price of $0.4626 compared to the original $3.57 exercise price. The Inducement Warrants and underlying shares are unregistered equity securities issued in reliance on Section 4(a)(2) exemption, materially affecting shareholder ownership and dilution.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 92%
filed 2026-06-09
Item 3.03
The Company effected a 1-for-20 reverse stock split solely to restore compliance with NASDAQ Capital Market's continued listing standards. This action addresses a material listing compliance failure and represents a significant delisting risk event.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-06-09
Item 1.01 discloses entry into a material definitive agreement on June 3, 2026: a limited liability company agreement establishing a joint venture (Soluna MB KK II JVCo, LLC) between Soluna HPC KK II HoldCo, LLC and DC Kati Venture LLC to develop and operate a multi-phase data center project ("Kati 2") in Texas. The Soluna Member is contributing approximately $3.5 million in initial funding plus committed capital of up to $21 million for Phase I (100 MW) and Phase II (250 MW) development, with defined return thresholds (14% IRR and $100,000 per Gross PPA MW) before profit-sharing. This constitutes a material joint venture investment and operational commitment that would affect investor assessment of the company's capital allocation and growth strategy.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-06-09
Applied Digital announced a $1.59 billion private offering of senior secured notes due 2031 by its subsidiary APLD ComputeCo 3 LLC, disclosed under Item 8.01. While technically debt rather than equity, this represents a material capital raise that will dilute existing shareholders' ownership percentage and is disclosed as a significant financing event. The offering is substantial in size and intended to fund major infrastructure development (150 MW at Ellendale) and repay bridge financing.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-09
The filing discloses entry into a long-term strategic agreement with Frankfort Plastics to supply 40,000 tons per year of polyolefin plastic waste to the Company's Cedar Port Waste to Fuels facility. While this represents a material commercial arrangement that would affect investor assessment of the company's operations and revenue prospects, it does not fit cleanly into the M&A taxonomy (no acquisition, merger, or change of control) and is disclosed under Item 8.01 (Other Events) rather than Items 1.01 or 2.01. The supply agreement is material but lacks the structural characteristics of a traditional M&A transaction.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-09
The filing discloses an unregistered sale of 79,618 shares of common stock to CEO Steven Rossi on June 5, 2026, at $0.6280 per share for $50,000.10, relying on Section 4(a)(2) exemption. Although the purchase price was satisfied through offset of accrued bonus compensation rather than cash, this is a dilutive equity issuance to an insider that would materially affect shareholder ownership and is properly classified under Item 3.02 (Unregistered Sales of Equity Securities).
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-06-09
The filing's primary disclosure under Item 1.01 is entry into a Binding Letter of Intent with FORCARA, LLC on June 8, 2026, establishing a framework for a strategic business relationship and definitive transaction whereby FORCARA would become part of the Company's operating platform. Although the final acquisition structure and terms remain subject to due diligence and definitive agreements, the binding interim joint venture with revenue-sharing (50/50 EBITDA split, $12,500/month management fee) and exclusivity provisions constitute a material M&A-related commitment. The filing also discloses complementary governance actions (Series K issuance, board appointment, Series R preferred stock authorization) supporting the strategic repositioning, but the LOI with FORCARA is the central material event.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-09
The filing discloses two distinct events under Item 8.01: (1) successful field performance and power generation from a PowerBuoy® system deployed for U.S. Coast Guard maritime domain awareness operations off San Diego, and (2) an inducement grant to a newly hired employee. The operational achievement represents a material milestone for a wave-energy technology company, though the filing provides minimal detail. The employee grant is routine compensation. Neither event fits the specific taxonomy categories—this is neither an earnings release (no financial results), exec_appointment (no named officer), exec_compensation (routine inducement grant), nor material_litigation. The operational success is material to investors assessing the company's technology viability and commercialization progress.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-09
The filing discloses results of Sanara MedTech's Annual Meeting of Shareholders held on June 4, 2026, under Item 5.07. The company reports voting outcomes for four proposals: election of nine directors, ratification of auditor Weaver and Tidwell L.L.P., advisory approval of named executive officer compensation, and frequency of future advisory votes on compensation. All proposals received sufficient votes for approval, with detailed vote tallies provided for each nominee and proposal.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-09
The filing discloses Item 5.07 results from XMax Inc.'s June 5, 2026 Annual Meeting of Shareholders, including voting outcomes for four proposals: election of six directors (Umesh Patel, Xiaohua Lu, Yizhou Zhao, Ming-Cherng Sky Tsai, Wen Tao, and Matthew Beck), ratification of Enrome LLP as independent auditor, advisory approval of named executive officer compensation, and advisory vote on compensation vote frequency. These are standard shareholder vote results that materially affect corporate governance and board composition.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 85%
filed 2026-06-09
The filing discloses modifications to compensatory arrangements for two named executives—Jose Vargas (Head of Business Development and board member) and Theodore Rosenthal (President of Digital Assets Division)—reducing their annual base salaries from $150,000 to $30,000 per annum effective May 11, 2026. This is a material change to executive compensation reflecting the Company's reduced scale of operations, disclosed under Item 5.02(e).
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-09
The filing discloses results of Fusemachines Inc.'s 2026 Annual Meeting of Stockholders held on June 9, 2026, under Item 5.07. Shareholders voted on three proposals: election of three Class I directors (Salman Alam, Bharat Krish, and Tim Gocher), approval of an amendment to the 2025 Omnibus Equity Incentive Plan to increase available shares by 2,000,000, and ratification of KNAV CPA LLP as independent auditor. Detailed voting results are provided for each proposal, making this a clear shareholder_vote_results disclosure that is material to investors.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-09
The filing discloses two unregistered equity issuances: (1) a PIPE transaction with Smart Dynamics Technology Limited for 20 million shares and 160 million warrants at $10 million aggregate consideration, and (2) a stock purchase agreement with Alset Inc. (the majority shareholder) for 250,000 shares at $500,000. Both securities are explicitly noted as unregistered under the Securities Act, relying on Section 4(a)(2) and Regulation D exemptions. The PIPE represents substantial dilution and is a classic private placement financing event material to investors.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-09
The filing discloses an At-The-Market (ATM) offering under which Enveric Biosciences filed a prospectus supplement on June 9, 2026 to offer an additional $2,425,000 of common stock shares pursuant to an ATM Agreement with H.C. Wainwright & Co., LLC dated April 9, 2025. The company has already sold $4,483,711.04 under this agreement. This is a dilutive equity issuance that would materially affect shareholders through equity dilution and is a strong signal of capital-raising activity typical of small- and mid-cap issuers.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-06-09
Applied Digital's subsidiary APLD ComputeCo 3 LLC priced a $1.59 billion offering of senior secured notes due 2031 at par (100%). While technically debt rather than equity, this represents a material capital raise that increases the company's financial obligations and dilutes equity holders' ownership percentage. The proceeds fund construction of critical infrastructure (150 MW at Ellendale) and repay bridge financing, making this a material financing event that would affect investor assessment of the registrant's capital structure and leverage.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-09
Item 1.01
Cycurion consummated a reverse merger transaction on June 3, 2026, in which its wholly owned subsidiary merged with and into Secuvant, LLC, with Secuvant surviving as a subsidiary of the Company. The transaction involved conversion of Secuvant's equity interests into merger consideration and succession of assets, liabilities, and operations, supported by Registration Rights, Lock-Up, Leak-Out, Escrow, Employment, and Advisory agreements.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-09
Item 5.03
The Company authorized 888,888 shares of Series I Convertible Preferred Stock with a stated value of $2.25 per share, convertible into Common Stock at the holder's option, with liquidation preferences and protective provisions. This amendment to the articles of incorporation represents a material capital structure change introducing new preferred equity with conversion and liquidation rights.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-09
The filing discloses entry into a long-term lease agreement for Delta Forge 2 Campus, a purpose-built AI Factory campus, announced via press release on June 8, 2026. While this represents a material operational commitment for Applied Digital's infrastructure expansion, it does not fit cleanly into the M&A taxonomy (not an acquisition, merger, or change of control) and is disclosed under Item 7.01 (Regulation FD Disclosure) rather than Items 1.01 or 2.01 typically used for material transactions. The lease of a major facility campus would be material to investors assessing the company's growth trajectory and capital commitments, but the disclosure format and Item classification suggest it is being treated as a significant operational announcement rather than a formal material acquisition or disposition.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-09
This 8-K discloses multiple material corporate developments under Item 8.01: (1) ongoing negotiations for a potential acquisition of Vision Aerial with active due diligence; (2) an anticipated amendment to the Kips financing transaction and planned resale registration statement for ~4.5M shares; (3) an expected stockholder meeting in July 2026 with proposals including share issuances to Kips, charter amendments, equity plan increases, and future fundraising authorization; and (4) settlement of two lawsuits and satisfaction of ~$3.74M in debt. While the Vision Aerial transaction remains non-binding and subject to definitive agreements, the combination of pending M&A activity, material financing transactions, significant debt reduction, and stockholder approval requirements for multiple capital-raising and governance matters would materially affect a reasonable investor's assessment of the company's financial condition and strategic direction. The filing does not fit neatly into a single category (it touches on ma_activity, dilutive_issuance, shareholder_vote_results, and material_litigation settlement), making other_material the most appropriate classification.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-09
Item 5.02
Jeffrey Ford was appointed as principal accounting officer of Fastly effective June 3, 2026, representing a significant change in the company's accounting leadership structure and oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-09
Item 5.07
Fastly held its 2026 Annual Meeting of Stockholders on June 3, 2026, with all three proposals passing by substantial majorities: election of three directors (Álvarez, Compton, Daniels), ratification of KPMG LLP as independent auditor, and advisory approval of named executive officer compensation.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-09
Item 7.01
FingerMotion announced entry into a non-binding Memorandum of Understanding with BlueFlare Energy Solutions to jointly develop a distributed network of edge AI inference compute sites across Western Canada, with a first project (PR1) involving 1.0 MW bitcoin mining infrastructure and planned 500 kW AI inference compute deployment. While the MOU and LOI are explicitly non-binding and subject to future definitive agreements and due diligence, the disclosure describes a material strategic partnership and infrastructure investment opportunity that would affect a reasonable investor's assessment of the company's growth strategy and market positioning in the AI inference sector. This does not fit cleanly into ma_activity (no binding acquisition or merger) but represents a material strategic development warranting disclosure.
View raw filing on EDGAR →
8-K
Auditor Change
confidence 95%
filed 2026-06-09
Item 4.01
The filing discloses the termination of Assure CPA, LLC as the Company's independent registered public accounting firm on June 3, 2026 (due to its merger into Sadler Gibb & Associates LLC) and the appointment of Sadler Gibb as the successor auditor on June 8, 2026. This is a classic auditor change under Item 4.01. Although the prior auditor's report contained a going-concern modification, the Company explicitly states there were no disagreements or reportable events, and the auditor's response letter (Exhibit 16.1) is attached. The change is material because auditor transitions affect investor confidence in financial reporting and audit quality.
View raw filing on EDGAR →
8-K
Cybersecurity Incident
confidence 98%
filed 2026-06-09
Item 8.01
The disclosure describes a material cybersecurity incident discovered on May 13, 2026, involving unauthorized access to customer data through a third-party support platform. The breach compromised financial institution clients' transaction records, payment card numbers, and customer names/contact information, primarily affecting Puerto Rico-based institutions. The Company has engaged law enforcement and external cybersecurity experts, expects to incur investigation and remediation expenses, and acknowledges potential liabilities and insurance coverage uncertainties—all hallmarks of a material cybersecurity incident requiring 8-K disclosure under Item 1.05 (mandatory since 2023).
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-09
Item 5.07
This Item 5.07 discloses the results of Oscar Health's 2026 Annual Meeting of Stockholders held on June 4, 2026, including voting outcomes for three proposals: election of eight directors, advisory approval of named executive officer compensation, and ratification of PricewaterhouseCoopers LLP as independent auditor. The filing presents detailed vote tallies (FOR, AGAINST, WITHHELD, ABSTAINED, and Broker Non-Votes) for each proposal and confirms all three items were approved, which is the core disclosure required under Item 5.07.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-09
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Allegion's 2026 annual general meeting held on June 4, 2026. The filing presents voting outcomes for six proposals: election of eight directors, advisory approval of named executive officer compensation, frequency of future compensation votes, ratification of PricewaterhouseCoopers as auditor, renewal of share issuance authority, and renewal of special share issuance authority. All proposals passed with substantial majorities, and the disclosure includes detailed vote tallies (For/Against/Abstain/Broker Non-Votes) for each proposal, which is the hallmark of shareholder vote results reporting.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-09
Item 2.02
The filing discloses a press release announcing financial results for the three months ended April 30, 2026 (first quarter of fiscal 2027), with a scheduled conference call to discuss those results. This is a classic earnings release disclosure under Item 2.02, and the results are material to investors' assessment of the company's operational performance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 93%
filed 2026-06-09
Item 5.02
Quanterix Corp appointed Jason Faessler as Chief Financial Officer and Treasurer, effective June 22, 2026. The appointment includes a base salary of $475,000, a sign-on bonus of $200,000, an RSU grant of 0.30% of outstanding shares, and severance provisions.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-09
Item 5.02
Craig Wichner was appointed Chief Executive Officer of Cibus, Inc. on June 8, 2026, as the culmination of the Company's previously announced succession planning strategy. Concurrent with his appointment as CEO, Wichner resigned from the Board of Directors and the Strategy Committee. The appointment includes compensatory arrangements consisting of RSU and stock option grants totaling $2.2 million, a base salary of $650,000, and specified severance terms.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-09
Item 5.07
This is a clear disclosure of shareholder vote results from Vera Bradley's 2026 Annual Meeting of Shareholders held on June 4, 2026, covering four matters: election of six directors, ratification of Deloitte & Touche LLP as independent auditor, advisory approval of named executive officer compensation, and approval of an amendment to the 2020 Equity and Incentive Plan. The filing presents detailed vote tallies (for, against, abstentions, and broker non-votes) for each matter, which is the hallmark of Item 5.07 disclosure and constitutes material information for investors regarding corporate governance and shareholder decisions.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-09
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Titan Machinery's Annual Meeting held on June 8, 2026. The filing presents voting tallies for three proposals: election of Class I directors (Christianson, Hamilton, Knutson), approval of named executive officer compensation, and ratification of Deloitte & Touche LLP as independent auditor. Shareholder vote results are material to investors as they reflect governance outcomes and stakeholder confidence in management and board composition.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-06-09
Item 7.01
The disclosure announces the closing of the previously announced acquisition of Onyx-Fire Protection Services, Inc., which constitutes completion of a material acquisition. Although the Item 7.01 disclosure also includes updated financial guidance, the primary event disclosed is the M&A completion, which is material to investors assessing the registrant's strategic direction and financial position.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-09
Item 5.07
Arcutis held its Annual Meeting of Stockholders on June 5, 2026, with shareholders voting on three proposals: election of three Class III directors, ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. All three proposals were approved.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-06-09
Item 8.01
The Board approved revisions to the Amended and Restated Non-Employee Director Compensation Program, which establishes annual cash and equity compensation arrangements for non-employee directors.
View raw filing on EDGAR →
8-K
Earnings release
confidence 85%
filed 2026-06-09
Item 7.01
The disclosure announces raising guidance for Q2 2026 and full year 2026, which constitutes material forward-looking financial guidance that would affect a reasonable investor's assessment of the company's expected performance. While the Item 7.01 designation and Regulation FD language indicate this is a non-binding disclosure, the substance is a material earnings/guidance announcement tied to the investor day event.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-09
Item 5.02
Martijn Dekker resigned as a director effective June 3, 2026. This is a clear departure of a director from the company, which is material to investors as it affects board composition and governance. The filing discloses the resignation date and the director's name explicitly.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-09
Item 2.02
BARK, Inc. disclosed its financial results for fiscal year ended March 31, 2026 via a press release furnished as Exhibit 99.1, providing investors with the company's periodic financial performance and results of operations.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-09
Item 8.01
The Board authorized a $40 million stock repurchase program, a material capital allocation decision that reflects management's confidence in intrinsic value and affects shareholder value and the company's financial strategy.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-09
Item 5.02
The disclosure centers on the Board's appointment of Joe Park as a director effective June 29, 2026, with assignment to the Audit and Finance and Risk Management Committees. This is a clear executive appointment event. While the section mentions compensation arrangements, the principal action disclosed is the appointment itself, not a compensation modification or arrangement distinct from the appointment.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-09
Item 2.02
The filing discloses a press release announcing financial results for the fiscal quarter ended March 30, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). This is a standard quarterly earnings release, which is material to investors as it provides periodic financial performance data essential to assessing the registrant's operational and financial condition.
View raw filing on EDGAR →